IRIS Accounts Production v25.2.0.378 SC370060 director 31.12.24 1.1.24 31.12.24 31.12.24 Medium entities These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. true true true false true true false false false false false false false false false false false false false false false false false false false false false false false false true false Ordinary 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC3700602023-12-31SC3700602024-12-31SC3700602024-01-012024-12-31SC3700602022-12-31SC3700602023-01-012023-12-31SC3700602023-12-31SC370060ns15:Scotland2024-01-012024-12-31SC370060ns14:PoundSterling2024-01-012024-12-31SC370060ns10:Director12024-01-012024-12-31SC370060ns10:Consolidated2024-12-31SC370060ns10:ConsolidatedGroupCompanyAccounts2024-01-012024-12-31SC370060ns10:PrivateLimitedCompanyLtd2024-01-012024-12-31SC370060ns10:Consolidatedns10:MediumEntities2024-01-012024-12-31SC370060ns10:Consolidatedns10:Audited2024-01-012024-12-31SC370060ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-01-012024-12-31SC370060ns10:Medium-sizedCompaniesRegimeForAccounts2024-01-012024-12-31SC370060ns10:Consolidated2024-01-012024-12-31SC370060ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-01-012024-12-31SC370060ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForAccounts2024-01-012024-12-31SC370060ns10:FullAccounts2024-01-012024-12-31SC370060ns5:Subsidiary12024-01-012024-12-31SC370060ns5:Subsidiary22024-01-012024-12-31SC370060ns5:Subsidiary32024-01-012024-12-31SC370060ns5:Subsidiary42024-01-012024-12-31SC370060ns5:Subsidiary52024-01-012024-12-31SC370060ns5:Subsidiary62024-01-012024-12-31SC370060ns5:Subsidiary72024-01-012024-12-31SC370060ns5:Subsidiary82024-01-012024-12-31SC370060ns5:Subsidiary92024-01-012024-12-31SC370060ns5:Subsidiary102024-01-012024-12-31SC370060ns5:Subsidiary112024-01-012024-12-31SC370060ns5:Subsidiary122024-01-012024-12-31SC370060ns5:Subsidiary132024-01-012024-12-31SC370060ns5:Subsidiary142024-01-012024-12-31SC370060ns5:Subsidiary152024-01-012024-12-31SC370060ns5:Subsidiary162024-01-012024-12-31SC370060ns5:Subsidiary172024-01-012024-12-31SC370060ns5:Subsidiary182024-01-012024-12-31SC370060ns5:Subsidiary192024-01-012024-12-31SC370060ns5:Subsidiary202024-01-012024-12-31SC370060ns5:Subsidiary212024-01-012024-12-31SC37006012024-01-012024-12-31SC370060ns10:OrdinaryShareClass12024-01-012024-12-31SC370060ns10:Consolidated2023-01-012023-12-31SC370060ns5:CurrentFinancialInstruments2024-12-31SC370060ns5:CurrentFinancialInstruments2023-12-31SC370060ns5:ShareCapital2024-12-31SC370060ns5:ShareCapital2023-12-31SC370060ns5:FurtherSpecificReserve1ComponentTotalEquity2024-12-31SC370060ns5:FurtherSpecificReserve1ComponentTotalEquity2023-12-31SC370060ns5:RetainedEarningsAccumulatedLosses2024-12-31SC370060ns5:RetainedEarningsAccumulatedLosses2023-12-31SC370060ns5:ShareCapital2022-12-31SC370060ns5:RetainedEarningsAccumulatedLosses2022-12-31SC370060ns5:FurtherSpecificReserve1ComponentTotalEquity2022-12-31SC370060ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-31SC370060ns5:FurtherSpecificReserve1ComponentTotalEquity2023-01-012023-12-31SC370060ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-31SC370060ns5:FurtherSpecificReserve1ComponentTotalEquity2024-01-012024-12-31SC370060ns5:NetGoodwill2024-01-012024-12-31SC370060ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-31SC370060ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-012024-12-31SC370060ns5:ComputerSoftware2024-01-012024-12-31SC370060ns5:PlantMachinery2024-01-012024-12-31SC370060ns5:FurnitureFittings2024-01-012024-12-31SC370060ns5:ComputerEquipment2024-01-012024-12-31SC370060ns5:NetGoodwill2023-12-31SC370060ns5:ComputerSoftware2023-12-31SC370060ns5:NetGoodwill2024-12-31SC370060ns5:ComputerSoftware2024-12-31SC370060ns5:NetGoodwill2023-12-31SC370060ns5:ComputerSoftware2023-12-31SC370060ns5:FurnitureFittings2023-12-31SC370060ns5:ComputerEquipment2023-12-31SC370060ns5:FurnitureFittings2024-12-31SC370060ns5:ComputerEquipment2024-12-31SC370060ns5:FurnitureFittings2023-12-31SC370060ns5:ComputerEquipment2023-12-31SC370060ns5:CostValuation2023-12-31SC370060ns5:UnlistedNon-exchangeTradedns5:CostValuation2023-12-31SC370060ns5:AdditionsToInvestments2024-12-31SC370060ns5:AdditionsToInvestmentsns5:UnlistedNon-exchangeTraded2024-12-31SC370060ns5:DisposalsRepaymentsInvestments2024-12-31SC370060ns5:UnlistedNon-exchangeTradedns5:DisposalsRepaymentsInvestments2024-12-31SC370060ns5:CostValuation2024-12-31SC370060ns5:UnlistedNon-exchangeTradedns5:CostValuation2024-12-31SC370060ns5:UnlistedNon-exchangeTraded2024-12-31SC370060ns5:UnlistedNon-exchangeTraded2023-12-31SC3700601ns5:Subsidiary12024-01-012024-12-31SC370060ns5:Subsidiary232024-01-012024-12-31SC3700605ns5:Subsidiary32024-01-012024-12-31SC3700607ns5:Subsidiary42024-01-012024-12-31SC370060ns5:Subsidiary592024-01-012024-12-31SC370060ns5:Subsidiary6112024-01-012024-12-31SC37006013ns5:Subsidiary72024-01-012024-12-31SC370060ns5:Subsidiary8152024-01-012024-12-31SC37006017ns5:Subsidiary92024-01-012024-12-31SC37006019ns5:Subsidiary102024-01-012024-12-31SC37006021ns5:Subsidiary112024-01-012024-12-31SC37006023ns5:Subsidiary122024-01-012024-12-31SC370060ns5:Subsidiary13252024-01-012024-12-31SC37006027ns5:Subsidiary142024-01-012024-12-31SC370060ns5:Subsidiary15292024-01-012024-12-31SC370060ns5:Subsidiary16312024-01-012024-12-31SC37006032ns5:Subsidiary172024-01-012024-12-31SC37006033ns5:Subsidiary182024-01-012024-12-31SC37006034ns5:Subsidiary192024-01-012024-12-31SC370060342024-01-012024-12-31SC370060ns5:Subsidiary20352024-01-012024-12-31SC37006036ns5:Subsidiary212024-01-012024-12-31SC370060ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-31SC370060ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31SC370060ns5:Non-currentFinancialInstruments2024-12-31SC370060ns5:Non-currentFinancialInstruments2023-12-31SC370060ns5:DeferredTaxation2023-12-31SC370060ns5:DeferredTaxation2024-01-012024-12-31SC370060ns5:DeferredTaxation2024-12-31SC370060ns10:OrdinaryShareClass12024-12-31SC370060ns5:RetainedEarningsAccumulatedLosses2023-12-31SC370060ns5:FurtherSpecificReserve1ComponentTotalEquity2023-12-31
REGISTERED NUMBER: SC370060 (Scotland)















Group Strategic Report, Report of the Director and

Audited Consolidated Financial Statements for the Year Ended 31 December 2024

for

Locogen Limited

Locogen Limited (Registered number: SC370060)






Contents of the Consolidated Financial Statements
for the Year Ended 31 December 2024




Page

Group Strategic Report 1

Report of the Director 4

Report of the Independent Auditors 5

Consolidated Statement of Comprehensive Income 8

Consolidated Balance Sheet 10

Company Balance Sheet 11

Consolidated Statement of Changes in Equity 12

Company Statement of Changes in Equity 13

Consolidated Cash Flow Statement 14

Notes to the Consolidated Cash Flow Statement 15

Notes to the Consolidated Financial Statements 16


Locogen Limited (Registered number: SC370060)

Group Strategic Report
for the Year Ended 31 December 2024

The director presents his strategic report of the company and the group for the year ended 31 December 2024.

The Locogen Group exists to accelerate the transition to a world powered by renewable energy. Our vision is to operate across the world, maximising the uptake of renewable energy systems by delivering leading expertise across the life cycle of renewable energy projects, while creating an environment where our people love to work, are inspired to grow, and empowered to make a difference.

We do this by providing expert consultancy services to support our clients to develop, build and operate renewable energy projects and co-investing with our partners to develop projects that deliver our vision. Our team provides comprehensive and unrivalled renewable energy systems expertise and focus on cultivating long-term, trusted relationships with our clients. We evoke confidence with our knowledge and leave clients inspired through our creative approach. We believe our people are core to our success, and by attracting and empowering a passionate and talented team, we provide world-class support to our clients and partners to develop, build, and operate renewable energy projects.

REVIEW OF BUSINESS
The business is committed to the continuous development and growth of our multidisciplinary consultancy team and of our investment in development activities. We have a strong track record of both providing specialist consultancy services to support clients on their projects, as well as co-investing alongside our partners in the development of our own portfolio of projects.

Since incorporation we have focused on reinvesting profits in the growth of the business and partnering with other developers to build long-term value for the group through our development activities. In 2024, we secured a substantial investment in our French business to fund the growth of our development activities in France. In the UK we have realised returns from our investment in development activities in utility scale solar and energy storage projects. These have provided the capital to reinvest in the growth of the consultancy team, our management systems and process and our development portfolio in the UK and internationally.


Locogen Limited (Registered number: SC370060)

Group Strategic Report
for the Year Ended 31 December 2024

PRINCIPAL RISKS AND UNCERTAINTIES
The operation of the business and implementation of its strategy are subject to several risks which are accepted and managed by the director and the senior management team. The company employs an integrated management system with regular reviews of policies, procedures and internal controls to ensure compliance with all relevant legislation and regulations.

The key risks affecting our clients and partners, which impact Locogen are:

Political, regulatory, and technical risks through changing government policy, planning and permitting delays, Contracts for Difference (CfD) reform, grid capacity constraints, grid connection reform, etc. These are being mitigated through active engagement with the market and our customers to gather intelligence on the risks and opportunities.

Macro national and international economic factors, including energy price volatility, inflation, cost of debt and equity, etc which are affecting our customers and partners appetite for investment in renewable energy projects. This is being mitigated through ongoing dialogue with our customers on the risks and opportunities for their business and the impact on Locogen.

Other key risks affecting Locogen include:

Attracting and retaining qualified and experienced staff in a competitive labour market. To mitigate this the company offers an environment for personal and professional development in a positive working culture combined with competitive benefits packages.

The market is competitive and there has been significant consolidation in recent years. To mitigate this risk, we maintain strong relationships with our clients and strive to offer service excellence and a more personal approach than our larger competitors.

The Group manages our working capital to meet our obligations to suppliers and financial institutions. The senior management team review management accounts against monthly budgets, particularly focusing on monitoring sales, gross margins and EBITDA in the consultancy business and development expenditure and direct costs in the development business to assist the forecasting of short-term and medium-term funding requirements.

The key credit risk in the consultancy business is in relation to trade debtors. We mitigate this risk by regularly monitoring trade debtors and by carrying out credit verification procedures for all clients.

The group finances its consultancy and development operations through retained profits. We finance the construction of our projects with debt. The interest rate on the debt is a mixture of fixed and variable. We review the financial performance and debt service cover ratio of our operational projects quarterly.

KEY PERFORMANCE INDICATORS
The director and senior management monitor financial performance every month and highlight the following key performance indicators:

KPI 2024 (£) 2023 (£)
Total income 9,171,068 11,246,679
Gross profit 1,966,223 2,342,670
Profit before tax 1,648,164 161,946
Net assets 6,349,272 4,741,745
Net current assets 4,037,759 2,813,880
Cash position 2,988,972 1,186,043


Locogen Limited (Registered number: SC370060)

Group Strategic Report
for the Year Ended 31 December 2024

FUTURE OUTLOOK
The UK renewable energy market is facing political, regulatory and technical challenges, particularly with grid capacity challenges, the grid reform process, changes and delays to the CfD mechanism, as well as inflation and the cost of capital. These factors are creating uncertainty for our customers and partners. We are monitoring the impact of these risks on our consultancy and development business on a regular basis and will reduce costs accordingly where required. We are confident that the market factors affecting uncertainty will be resolved in 2026 and we expect significant growth in both the consultancy and development business in the future.

ON BEHALF OF THE BOARD:





Mr A W Lyle - Director


25 September 2025

Locogen Limited (Registered number: SC370060)

Report of the Director
for the Year Ended 31 December 2024

The director presents his report with the financial statements of the company and the group for the year ended 31 December 2024.

PRINCIPAL ACTIVITY
The principal activity of the group in the year under review was that of renewable energy consultants.

DIVIDENDS
The total distribution for dividends for the year ended 31 December 2024 will be £1,220,000.

DIRECTOR
Mr A W Lyle held office during the whole of the period from 1 January 2024 to the date of this report.

STATEMENT OF DIRECTOR'S RESPONSIBILITIES
The director is responsible for preparing the Group Strategic Report, the Report of the Director and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the director is required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and he has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

AUDITORS
Drummond Laurie CA are deemed to be reappointed under section 487(2) of the Companies Act 2006.

ON BEHALF OF THE BOARD:





Mr A W Lyle - Director


25 September 2025

Report of the Independent Auditors to the Members of
Locogen Limited

Opinion
We have audited the financial statements of Locogen Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2024 which comprise the Consolidated Statement of Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 31 December 2024 and of the group's profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

Other information
The director is responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Director, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Director for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Director have been prepared in accordance with applicable legal requirements.
In the previous accounting period, the group was exempt from the requirement to have its financial statements audited under section 477 of the Companies Act 2006. Therefore, the prior period financial statements were not subject to audit.

Report of the Independent Auditors to the Members of
Locogen Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Director.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of director's remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of director
As explained more fully in the Statement of Director's Responsibilities set out on page four, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the group or the parent company or to cease operations, or has no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities outlined above to detect material misstatements in respect of irregularities, including fraud.

Based on our understanding of the group, we identified that the principal risks of non-compliance with laws and regulations related to fraudulent manipulation of the financial statements, including the risk of override of controls, to reduce profits and tax liabilities. We determined that the most likely method of manipulation would be the posting of inappropriate journal entries. Audit procedures performed by the audit engagement team consisted of a review of large and unusual journal entries, challenging assumptions and judgements made by management in significant accounting estimates, discussions with management related to known or suspected instances of non-compliance with laws and regulations, review of Board minutes where available, and an evaluation of management controls designed to prevent and detect irregularities.

There are inherent limitations in the audit procedures described above and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations or through collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Locogen Limited


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Craig Clinton (Senior Statutory Auditor)
for and on behalf of Drummond Laurie CA
Statutory Auditor
Unit 5
Gateway Business Park
Beancross Road
Grangemouth
FK3 8WX

26 September 2025

Locogen Limited (Registered number: SC370060)

Consolidated Statement of Comprehensive Income
for the Year Ended 31 December 2024

31.12.24 31.12.23
Notes £    £   

TURNOVER 3 6,236,317 8,001,275

Cost of sales (4,270,094 ) (5,658,605 )
GROSS PROFIT 1,966,223 2,342,670

Administrative expenses (3,041,643 ) (5,263,494 )
(1,075,420 ) (2,920,824 )

Other operating income 240,824 3,149,107
OPERATING (LOSS)/PROFIT 5 (834,596 ) 228,283

Income from interest in associated
undertakings

819,915

-
Income from other participating interests 1,721,987 -
Interest receivable and similar income 152,025 96,297
1,859,331 324,580
Amounts written off investments 6 (77,171 ) (49,249 )
1,782,160 275,331

Interest payable and similar expenses 7 (133,996 ) (113,385 )
PROFIT BEFORE TAXATION 1,648,164 161,946

Tax on profit 8 (75,352 ) (113,691 )
PROFIT FOR THE FINANCIAL YEAR 1,572,812 48,255

OTHER COMPREHENSIVE INCOME
Minority interest investment increase 685,734 -
Income tax relating to other comprehensive
income

-

-
OTHER COMPREHENSIVE INCOME
FOR THE YEAR, NET OF INCOME TAX

685,734

-
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

2,258,546

48,255

Profit attributable to:
Owners of the parent 1,542,243 79,053
Non-controlling interests 30,569 (30,798 )
1,572,812 48,255

Total comprehensive income attributable to:
Owners of the parent 2,227,976 79,053
Non-controlling interests 30,570 (30,798 )

Locogen Limited (Registered number: SC370060)

Consolidated Statement of Comprehensive Income
for the Year Ended 31 December 2024

31.12.24 31.12.23
£    £   
2,258,546 48,255

Locogen Limited (Registered number: SC370060)

Consolidated Balance Sheet
31 December 2024

31.12.24 31.12.23
Notes £    £   
FIXED ASSETS
Intangible assets 11 725,850 266,998
Tangible assets 12 3,205,049 3,320,631
Investments 13
Interest in joint venture 50 50
Interest in associate 16,453 56,558
Other investments 276,864 317,793
4,224,266 3,962,030

CURRENT ASSETS
Stocks 14 272,401 117,766
Debtors 15 3,280,250 3,553,207
Cash at bank 2,988,972 1,186,043
6,541,623 4,857,016
CREDITORS
Amounts falling due within one year 16 (2,503,864 ) (2,043,136 )
NET CURRENT ASSETS 4,037,759 2,813,880
TOTAL ASSETS LESS CURRENT
LIABILITIES

8,262,025

6,775,910

CREDITORS
Amounts falling due after more than one
year

17

(1,661,920

)

(1,865,038

)

PROVISIONS FOR LIABILITIES 20 (250,833 ) (169,127 )
NET ASSETS 6,349,272 4,741,745

CAPITAL AND RESERVES
Called up share capital 21 1,000 1,000
Other reserves 22 77,633 77,633
Retained earnings 22 5,965,088 4,957,111
SHAREHOLDERS' FUNDS 6,043,721 5,035,744

NON-CONTROLLING INTERESTS 23 305,551 (293,999 )
TOTAL EQUITY 6,349,272 4,741,745

The financial statements were approved by the director and authorised for issue on 25 September 2025 and were signed by:




Mr A W Lyle - Director


Locogen Limited (Registered number: SC370060)

Company Balance Sheet
31 December 2024

31.12.24 31.12.23
Notes £    £   
FIXED ASSETS
Intangible assets 11 - 280
Tangible assets 12 49,093 35,582
Investments 13 1,101,785 542,794
1,150,878 578,656

CURRENT ASSETS
Debtors 15 3,221,199 6,081,450
Cash at bank 1,771,718 430,982
4,992,917 6,512,432
CREDITORS
Amounts falling due within one year 16 (951,806 ) (705,686 )
NET CURRENT ASSETS 4,041,111 5,806,746
TOTAL ASSETS LESS CURRENT
LIABILITIES

5,191,989

6,385,402

PROVISIONS FOR LIABILITIES 20 (9,328 ) -
NET ASSETS 5,182,661 6,385,402

CAPITAL AND RESERVES
Called up share capital 21 1,000 1,000
Other reserves 22 77,633 77,633
Retained earnings 22 5,104,028 6,306,769
SHAREHOLDERS' FUNDS 5,182,661 6,385,402

Company's profit for the financial year 17,259 29,309

The financial statements were approved by the director and authorised for issue on 25 September 2025 and were signed by:





Mr A W Lyle - Director


Locogen Limited (Registered number: SC370060)

Consolidated Statement of Changes in Equity
for the Year Ended 31 December 2024

Called up
share Retained Other
capital earnings reserves
£    £    £   
Balance at 1 January 2023 1,000 4,878,058 77,633

Changes in equity
Total comprehensive income - 79,053 -
Balance at 31 December 2023 1,000 4,957,111 77,633

Changes in equity
Dividends - (1,220,000 ) -
Total comprehensive income - 2,227,977 -
1,000 5,965,088 77,633
Minority interest investment - - -
Investment reserves movement - - -
Balance at 31 December 2024 1,000 5,965,088 77,633
Non-controlling Total
Total interests equity
£    £    £   
Balance at 1 January 2023 4,956,691 (263,201 ) 4,693,490

Changes in equity
Total comprehensive income 79,053 (30,798 ) 48,255
Balance at 31 December 2023 5,035,744 (293,999 ) 4,741,745

Changes in equity
Dividends (1,220,000 ) (103,300 ) (1,323,300 )
Total comprehensive income 2,227,977 30,570 2,258,547
6,043,721 (366,729 ) 5,676,992
Minority interest investment - 1,358,014 1,358,014
Investment reserves movement - (685,734 ) (685,734 )
Balance at 31 December 2024 6,043,721 305,551 6,349,272

Locogen Limited (Registered number: SC370060)

Company Statement of Changes in Equity
for the Year Ended 31 December 2024

Called up
share Retained Other Total
capital earnings reserves equity
£    £    £    £   
Balance at 1 January 2023 1,000 6,277,460 77,633 6,356,093

Changes in equity
Total comprehensive income - 29,309 - 29,309
Balance at 31 December 2023 1,000 6,306,769 77,633 6,385,402

Changes in equity
Dividends - (1,220,000 ) - (1,220,000 )
Total comprehensive income - 17,259 - 17,259
Balance at 31 December 2024 1,000 5,104,028 77,633 5,182,661

Locogen Limited (Registered number: SC370060)

Consolidated Cash Flow Statement
for the Year Ended 31 December 2024

31.12.24 31.12.23
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 (904,777 ) 885,336
Interest paid (133,996 ) (113,385 )
Tax paid 11,943 (10,502 )
Net cash from operating activities (1,026,830 ) 761,449

Cash flows from investing activities
Purchase of intangible fixed assets (599,503 ) (127,221 )
Purchase of tangible fixed assets (34,879 ) (8,798 )
Sale of intangible fixed assets 16,759 69,000
Sale of fixed asset investments 22,017 21,080
Interest received 152,025 96,297
Dividends received 2,541,902 -
Net cash from investing activities 2,098,321 50,358

Cash flows from financing activities
New loans in year 684,225 -
Loan repayments in year (93,499 ) (1,000,399 )
Amount introduced by directors 6,900 -
Amount withdrawn by directors - (6,900 )
Investment by minority interest 1,353,812 -
Equity dividends paid (1,220,000 ) -
Net cash from financing activities 731,438 (1,007,299 )

Increase/(decrease) in cash and cash equivalents 1,802,929 (195,492 )
Cash and cash equivalents at beginning of
year

2

1,186,043

1,381,535

Cash and cash equivalents at end of year 2 2,988,972 1,186,043

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Cash Flow Statement
for the Year Ended 31 December 2024

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

31.12.24 31.12.23
£    £   
Profit before taxation 1,648,164 161,946
Depreciation charges 150,741 154,625
Profit on disposal of fixed assets - (69,000 )
Amounts written off investments 77,171 49,249
Finance costs 133,996 113,385
Finance income (2,693,927 ) (96,297 )
(683,855 ) 313,908
Increase in stocks (154,635 ) (47,620 )
Decrease in trade and other debtors 248,143 692,491
Decrease in trade and other creditors (314,430 ) (73,443 )
Cash generated from operations (904,777 ) 885,336

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 December 2024
31.12.24 1.1.24
£    £   
Cash and cash equivalents 2,988,972 1,186,043
Year ended 31 December 2023
31.12.23 1.1.23
£    £   
Cash and cash equivalents 1,186,043 1,381,535


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.1.24 Cash flow At 31.12.24
£    £    £   
Net cash
Cash at bank 1,186,043 1,802,929 2,988,972
1,186,043 1,802,929 2,988,972
Debt
Debts falling due within 1 year (303,714 ) (684,855 ) (988,569 )
Debts falling due after 1 year (1,334,274 ) 93,499 (1,240,775 )
(1,637,988 ) (591,356 ) (2,229,344 )
Total (451,945 ) 1,211,573 759,628

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements
for the Year Ended 31 December 2024

1. STATUTORY INFORMATION

Locogen Limited is a private company, limited by shares, domiciled in Scotland, registration number SC370060. The registered office is 4 West Silvermills Lane, Edinburgh, Scotland, EH3 5BD.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Basis of consolidation
The consolidated financial statements incorporate the financial statements of the company and all group undertakings. These are adjusted, where appropriate, to conform to group accounting policies. Acquisitions are accounted for under the acquisition method and goodwill on consolidation is capitalised and written off over five years from the year of acquisition. The results of companies acquired or disposed of are included in the profit and loss account after or up to the date that control passes respectively. As a consolidated profit and loss account is published, a separate profit and loss account for the parent company is omitted from the group financial statements by virtue of section 408 of the Companies Act 2006.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Transactions between group entities which have been eliminated on consolidation are not disclosed within the financial statements.

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued

Turnover
Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT.

Service contracts
Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to subcontracted services, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

Construction contracts
Where the outcome of a construction contract can be estimated reliably, revenue and costs are recognised by reference to the stage of completion of the contract activity at the reporting end date. Variations in contract work, claims and incentive payments are included to the extent that the amount can be measured reliably and its receipt is considered probable.

When it is probable that total contract costs will exceed total contract turnover, the expected loss is recognised as an expense immediately. Where the outcome of a construction contract cannot be estimated reliably, contract revenue is recognised to the extent of contract costs incurred where it is probable that they will be recoverable.

Contract costs are recognised as expenses in the period in which they are incurred. When costs incurred in securing a contract are recognised as an expense in the period in which they are incurred, they are not included in contract costs if the contract is obtained in a subsequent period.

The percentage of completion method is used to determine the appropriate amount to recognise in a given period. The stage of completion is measured by the proportion of contract costs incurred for work performed to date compared to the estimated total contract costs. Costs incurred in the year in connection with future activity on a contract are excluded from contract costs in determining the stage of completion. These costs are presented as stocks, prepayments or other assets depending on the nature, provided it is probable they will be recovered.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2018, is being amortised evenly over its estimated useful life of five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

An impairment loss has been recognised in the Consolidated Statement of Comprehensive Income, following an assessment at the Consolidated Balance Sheet date indicating the recoverable amount was less than its carrying value.

Development costs are being amortised evenly over their estimated useful life of ten years.

Other intangibles is being amortised evenly over its estimated useful life of four years.

Costs incurred in respect of the development phase of a project are recognised as an intangible asset, when certain specific criteria are met in order to demonstrate that the asset will generate probable future economic benefits and that its cost can be reliably measured. Once the project is in construction phase, the development costs are transferred to tangible assets. Assets in the course of development are not amortised.

Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued

Tangible fixed assets and depreciation
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 5% on cost and 2% on cost
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Tangible fixed assets are stated at cost less depreciation. Cost represent purchase price together with any incidental costs of acquisition.

The directors have considered the residual value of all tangible fixed assets to be immaterial and therefore all tangible fixed assets are depreciated to nil value.

Government grants
Grants are recognised in income when the grant proceeds are received or receivable provided that the terms of the grant do not impose future performance-related conditions. If the terms of a grant do impose performance-related conditions on the recipient, the grant is only recognised in income when the performance-related conditions are met. Any grants that are received before the revenue recognition criteria are met are recognised in the entity’s financial statements as a liability.

Investments in associates
Investments in associate undertakings are recognised at cost.

Investments in joint ventures
Investments in joint ventures are recognised at cost.

Unlisted investments
Unlisted investments are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. Cost is represented by purchase price.

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Financial assets
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

If transaction costs are immaterial and the credit period is short, amortised cost is equal to the nominal value less any allowance for credit losses. Amortised interest is recognised as Interest income within the Income Statement.

Where loans are provided interest-free or below market rate, the market value on initial recognition is required to be estimated by discounting the loan amount to the present value of future payments using an equivalent rate of a similar instrument.

Financial liabilities
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

If transaction costs are immaterial and the credit period is short, amortised cost is equal to the nominal value. The amortisation of financial liabilities is recognised as an Interest expense within the Income Statement.

Where loans are provided interest-free or below market rate, the market value on initial recognition is required to be estimated by discounting the loan amount to the present value of future payments using an equivalent rate of a similar instrument.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

Provisions
Provisions are recognised when the company has a legal or constructive obligation as a result of a past event, it is probable that an outflow of resources will be required to settle the obligation, and the amount has been reliably estimated. Provisions are not recognised for future operating losses. Provisions are discounted where the time value of money is material.

Where there are a number of similar obligations, the likelihood that an outflow will be required in settlement is determined by considering the class of obligations as a whole. A provision is recognised even if the likelihood of an outflow with respect to any one item included in the same class of obligations may be small.

Cash and cash equivalents
Cash and cash equivalents include cash at bank and in hand and highly liquid interest-bearing securities with maturities of three months or less. In the cash-flow statement, cash and cash equivalents are shown net of bank overdrafts, which are included as current borrowings in liabilities on the balance sheet.

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the group.

An analysis of turnover by geographical market is given below:

31.12.24 31.12.23
£    £   
United Kingdom 5,752,235 7,573,993
Europe 484,082 427,282
6,236,317 8,001,275

4. EMPLOYEES AND DIRECTORS
31.12.24 31.12.23
£    £   
Wages and salaries 3,431,355 2,896,823
Social security costs 472,562 349,316
Other pension costs 112,073 111,169
4,015,990 3,357,308

The average number of employees during the year was as follows:
31.12.24 31.12.23

Employees 79 64

The average number of employees by undertakings that were proportionately consolidated during the year was 14 (2023 - 7 ) .

31.12.24 31.12.23
£    £   
Director's remuneration 87,288 88,173

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

5. OPERATING (LOSS)/PROFIT

The operating loss (2023 - operating profit) is stated after charging/(crediting):

31.12.24 31.12.23
£    £   
Hire of plant and machinery 2,009 2,493
Other operating leases 135,758 97,152
Depreciation - owned assets 150,461 153,950
Profit on disposal of fixed assets - (69,000 )
Other intangibles amortisation 280 675
Auditors' remuneration 70,500 -
Foreign exchange differences (14,751 ) 60,427

6. AMOUNTS WRITTEN OFF INVESTMENTS
31.12.24 31.12.23
£    £   
Amounts w/o invs 77,171 49,249

7. INTEREST PAYABLE AND SIMILAR EXPENSES
31.12.24 31.12.23
£    £   
Interest on overdue taxation 341 137
Other interest 133,655 113,248
133,996 113,385

8. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
31.12.24 31.12.23
£    £   
Current tax:
UK corporation tax 754 10,750
Under/overprovision (7,108 ) (17,101 )
Total current tax (6,354 ) (6,351 )

Deferred tax 81,706 120,042
Tax on profit 75,352 113,691

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

8. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below:

31.12.24 31.12.23
£    £   
Profit before tax 1,648,164 161,946
Profit multiplied by the standard rate of corporation tax in the UK of 25 %
(2023 - 23.500 %)

412,041

38,057

Effects of:
Expenses not deductible for tax purposes 40,071 4,048
Income not taxable for tax purposes (635,475 ) (16,215 )
Depreciation in excess of capital allowances 28,965 34,269
Utilisation of tax losses - (66,510 )
Adjustments to tax charge in respect of previous periods (7,108 ) -
Deferred tax movement 81,706 120,042
Unused tax losses 155,152 -
Total tax charge 75,352 113,691

Tax effects relating to effects of other comprehensive income

31.12.24
Gross Tax Net
£    £    £   
Minority interest investment increase 685,734 - 685,734

9. INDIVIDUAL STATEMENT OF COMPREHENSIVE INCOME

As permitted by Section 408 of the Companies Act 2006, the Statement of Comprehensive Income of the parent company is not presented as part of these financial statements.


10. DIVIDENDS
31.12.24 31.12.23
£    £   
Ordinary shares of £1 each
Final 1,220,000 -

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

11. INTANGIBLE FIXED ASSETS

Group
Development Other
Goodwill costs intangibles Totals
£    £    £    £   
COST
At 1 January 2024 21,948 266,718 15,387 304,053
Additions - 527,169 72,334 599,503
Disposals (21,948 ) (16,759 ) (15,387 ) (54,094 )
Impairments - (123,612 ) - (123,612 )
At 31 December 2024 - 653,516 72,334 725,850
AMORTISATION
At 1 January 2024 21,948 - 15,107 37,055
Amortisation for year - - 280 280
Eliminated on disposal (21,948 ) - (15,387 ) (37,335 )
At 31 December 2024 - - - -
NET BOOK VALUE
At 31 December 2024 - 653,516 72,334 725,850
At 31 December 2023 - 266,718 280 266,998

Company
Other
Goodwill intangibles Totals
£    £    £   
COST
At 1 January 2024 21,948 12,387 34,335
Disposals (21,948 ) (12,387 ) (34,335 )
At 31 December 2024 - - -
AMORTISATION
At 1 January 2024 21,948 12,107 34,055
Amortisation for year - 280 280
Eliminated on disposal (21,948 ) (12,387 ) (34,335 )
At 31 December 2024 - - -
NET BOOK VALUE
At 31 December 2024 - - -
At 31 December 2023 - 280 280

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

12. TANGIBLE FIXED ASSETS

Group
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 January 2024 4,148,520 42,524 75,480 4,266,524
Additions - 25,544 9,335 34,879
At 31 December 2024 4,148,520 68,068 84,815 4,301,403
DEPRECIATION
At 1 January 2024 865,254 34,118 46,521 945,893
Charge for year 136,517 5,768 8,176 150,461
At 31 December 2024 1,001,771 39,886 54,697 1,096,354
NET BOOK VALUE
At 31 December 2024 3,146,749 28,182 30,118 3,205,049
At 31 December 2023 3,283,266 8,406 28,959 3,320,631

Company
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 January 2024 31,400 75,480 106,880
Additions 17,315 9,335 26,650
At 31 December 2024 48,715 84,815 133,530
DEPRECIATION
At 1 January 2024 24,777 46,521 71,298
Charge for year 4,963 8,176 13,139
At 31 December 2024 29,740 54,697 84,437
NET BOOK VALUE
At 31 December 2024 18,975 30,118 49,093
At 31 December 2023 6,623 28,959 35,582

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

13. FIXED ASSET INVESTMENTS

Group
Interest Interest
in joint in Unlisted
venture associate investments Totals
£    £    £    £   
COST
At 1 January 2024 50 56,558 317,793 374,401
Disposals - - (22,017 ) (22,017 )
Impairments - (40,105 ) (18,912 ) (59,017 )
At 31 December 2024 50 16,453 276,864 293,367
NET BOOK VALUE
At 31 December 2024 50 16,453 276,864 293,367
At 31 December 2023 50 56,558 317,793 374,401
Company
Shares in
group Unlisted
undertakings investments Totals
£    £    £   
COST
At 1 January 2024 331,390 211,404 542,794
Additions 824,800 - 824,800
Disposals (247,656 ) (18,153 ) (265,809 )
At 31 December 2024 908,534 193,251 1,101,785
NET BOOK VALUE
At 31 December 2024 908,534 193,251 1,101,785
At 31 December 2023 331,390 211,404 542,794

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiaries

Locogen Energy Services Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Energy saving equipment installation/maintenance
%
Class of shares: holding
Ordinary 100.00

Locogen Consulting Ltd
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Environmental consultancy
%
Class of shares: holding
Ordinary 100.00

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

13. FIXED ASSET INVESTMENTS - continued

Locogen Yieldco Ltd
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Business development
%
Class of shares: holding
Ordinary 100.00

Ben Mor Hydro Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Renewable electricity production
%
Class of shares: holding
Ordinary 100.00

Locogen Investments Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Investment holding
%
Class of shares: holding
Ordinary 100.00

Mid Whitestones Solar Ltd
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Renewable energy production
%
Class of shares: holding
Ordinary 100.00

Locogen Asset Management Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Asset management
%
Class of shares: holding
Ordinary 100.00

Locogen Devco Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00

Glenwhan Wind Farm Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Renewable energy production
%
Class of shares: holding
Ordinary 100.00

Locogen Developments Holdings Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Business development
%
Class of shares: holding
Ordinary 100.00

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

13. FIXED ASSET INVESTMENTS - continued

Locogen Solar Partnership Two Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Investment holdings
%
Class of shares: holding
Ordinary 100.00

Greenland Wind Farm Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Renewable energy production
%
Class of shares: holding
Ordinary 100.00

Arbikie Distillery Green Hydrogen Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Renewable energy production
%
Class of shares: holding
Ordinary 50.10

Locogen SPV Nine Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00

Locogen SPV Ten Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00

Locogen SPV Eleven Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00

Locogen SPV Twelve Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00

Locogen SPV Thirteen Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

13. FIXED ASSET INVESTMENTS - continued

Locogen SPV Fourteen Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00

Cantlayhills Energy Limited
Registered office: 4 West Silvermills Lane, Edinburgh, EH3 5BD
Nature of business: Renewable energy production
%
Class of shares: holding
Ordinary 51.00

SAS Locogen France
Registered office: 34 Rue Frederic le Guyader, 35200 Rennes
Nature of business: Business development
%
Class of shares: holding
Ordinary 59.23


14. STOCKS

Group
31.12.24 31.12.23
£    £   
Stocks 9,000 18,000
Work-in-progress 263,401 99,766
272,401 117,766

15. DEBTORS

Group Company
31.12.24 31.12.23 31.12.24 31.12.23
£    £    £    £   
Amounts falling due within one year:
Trade debtors 928,543 714,666 194,943 469,509
Amounts owed by group undertakings - - 2,111,640 2,371,727
Amounts owed by joint ventures 49,540 302,818 - -
Amounts owed by related parties 656,698 534,741 97,749 92,773
Amounts recoverable on contract 174,490 156,123 - -
Other debtors 28,240 - - -
Directors' current accounts - 6,900 - 6,900
Tax - 17,914 - 17,914
Deferred tax asset - - - 12,835
Prepayments and accrued income 757,347 718,471 202,341 430,591
2,594,858 2,451,633 2,606,673 3,402,249

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

15. DEBTORS - continued

Group Company
31.12.24 31.12.23 31.12.24 31.12.23
£    £    £    £   
Amounts falling due after more than one year:
Amounts owed by group undertakings - - 158,625 2,187,174
Amounts owed by related parties 685,392 1,101,574 455,901 492,027
685,392 1,101,574 614,526 2,679,201

Aggregate amounts 3,280,250 3,553,207 3,221,199 6,081,450

16. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
31.12.24 31.12.23 31.12.24 31.12.23
£    £    £    £   
Bank loans and overdrafts (see note 18) 872,866 188,641 - -
Other loans (see note 18) 115,703 115,073 - -
Payments on account 4,576 5,986 - -
Trade creditors 369,536 406,908 109,485 283,914
Amounts owed to group undertakings - - 379,470 -
Amounts owed to related parties 132,787 121,914 - -
Tax 754 13,079 - 2,329
Social security and other taxes 156,994 102,663 90,857 77,735
VAT 162,801 225,647 218,350 121,389
Other creditors 101,904 124,282 - -
Accruals and deferred income 585,943 738,943 153,644 220,319
2,503,864 2,043,136 951,806 705,686

17. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

Group
31.12.24 31.12.23
£    £   
Other loans (see note 18) 1,240,775 1,334,274
Amounts owed to related parties 421,145 492,289
Other creditors - 38,475
1,661,920 1,865,038

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

18. LOANS

An analysis of the maturity of loans is given below:

Group
31.12.24 31.12.23
£    £   
Amounts falling due within one year or on demand:
Bank loans 872,866 188,641
Other loans 115,703 115,073
988,569 303,714
Amounts falling due between one and two years:
Other loans - 1-2 years 97,956 97,956
Amounts falling due between two and five years:
Other loans - 2-5 years 351,452 351,452
Amounts falling due in more than five years:
Repayable by instalments
Other loans more 5yrs instal 791,367 884,866

19. SECURED DEBTS

The company has provided a guarantee in favour of Clydesdale Bank in respect of a loan granted to a company controlled by the director. This had a value of £479,404 at the year-end.

20. PROVISIONS FOR LIABILITIES

Group Company
31.12.24 31.12.23 31.12.24 31.12.23
£    £    £    £   
Deferred tax 250,833 169,127 9,328 -

Group
Deferred
tax
£   
Balance at 1 January 2024 169,127
Provided during year 81,706
Balance at 31 December 2024 250,833

Company
Deferred
tax
£   
Balance at 1 January 2024 (12,835 )
Provided during year 22,163
Balance at 31 December 2024 9,328

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

21. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.24 31.12.23
value: £    £   
1,000 Ordinary £1 1,000 1,000

22. RESERVES

Group
Retained Other
earnings reserves Totals
£    £    £   

At 1 January 2024 4,957,111 77,633 5,034,744
Profit for the year 1,542,243 1,542,243
Dividends (1,220,000 ) (1,220,000 )
Transfer 685,734 - 685,734
At 31 December 2024 5,965,088 77,633 6,042,721

Company
Retained Other
earnings reserves Totals
£    £    £   

At 1 January 2024 6,306,769 77,633 6,384,402
Profit for the year 17,259 17,259
Dividends (1,220,000 ) (1,220,000 )
At 31 December 2024 5,104,028 77,633 5,181,661


23. NON-CONTROLLING INTERESTS

Non-controlling interests hold a 40.77% interest in Locogen France SAS which has net assets of £659,579.

Non-controlling interests hold a 49.9% interest in Arbikie Distillery Green Hydrogen Limited which has net liabilities of £57,001.

Non-controlling interests hold a 49% interest in Cantlayhills Energy Limited which has net assets of £96,076.

Locogen Limited (Registered number: SC370060)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 December 2024

24. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2024 and 31 December 2023:

31.12.24 31.12.23
£    £   
Mr A W Lyle
Balance outstanding at start of year 6,900 -
Amounts advanced - 6,900
Amounts repaid (6,900 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 6,900

25. ULTIMATE CONTROLLING PARTY

The controlling party is Mr A W Lyle.